Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 6 | 2023 | 329 | 1.170 |
Why?
|
| Hepatitis, Alcoholic | 7 | 2023 | 78 | 1.150 |
Why?
|
| Receptors, CCR2 | 2 | 2020 | 13 | 0.800 |
Why?
|
| Macrophages | 6 | 2022 | 1035 | 0.710 |
Why?
|
| Central Nervous System Depressants | 2 | 2018 | 46 | 0.680 |
Why?
|
| Brain | 2 | 2020 | 1589 | 0.680 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 59 | 0.640 |
Why?
|
| Liver Diseases, Alcoholic | 5 | 2019 | 92 | 0.610 |
Why?
|
| Inflammasomes | 3 | 2023 | 347 | 0.590 |
Why?
|
| Fatty Liver | 2 | 2017 | 111 | 0.590 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 261 | 0.580 |
Why?
|
| Encephalitis | 1 | 2018 | 37 | 0.560 |
Why?
|
| Sex Characteristics | 1 | 2020 | 210 | 0.550 |
Why?
|
| Neutrophil Infiltration | 2 | 2017 | 64 | 0.520 |
Why?
|
| Microglia | 1 | 2020 | 250 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 3467 | 0.510 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 321 | 0.510 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2018 | 261 | 0.480 |
Why?
|
| Inflammation | 4 | 2023 | 1184 | 0.440 |
Why?
|
| Cytokines | 1 | 2018 | 950 | 0.430 |
Why?
|
| Hepatocytes | 6 | 2022 | 222 | 0.350 |
Why?
|
| Signal Transduction | 3 | 2020 | 3137 | 0.340 |
Why?
|
| CCR5 Receptor Antagonists | 2 | 2020 | 17 | 0.310 |
Why?
|
| Mice | 12 | 2023 | 11071 | 0.290 |
Why?
|
| Fatty Liver, Alcoholic | 3 | 2019 | 33 | 0.280 |
Why?
|
| Animals | 15 | 2023 | 21264 | 0.270 |
Why?
|
| MicroRNAs | 3 | 2019 | 704 | 0.260 |
Why?
|
| Autophagy | 2 | 2019 | 231 | 0.250 |
Why?
|
| Female | 15 | 2024 | 33804 | 0.240 |
Why?
|
| Psychomotor Agitation | 1 | 2024 | 20 | 0.210 |
Why?
|
| Clinical Alarms | 1 | 2024 | 12 | 0.210 |
Why?
|
| Hepatitis | 1 | 2023 | 58 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 795 | 0.170 |
Why?
|
| Macrophage Activation | 2 | 2019 | 115 | 0.170 |
Why?
|
| Headache | 1 | 2021 | 57 | 0.170 |
Why?
|
| Dyspnea | 1 | 2021 | 120 | 0.170 |
Why?
|
| Sulfoxides | 1 | 2020 | 15 | 0.170 |
Why?
|
| Imidazoles | 1 | 2020 | 81 | 0.160 |
Why?
|
| para-Aminobenzoates | 1 | 2020 | 2 | 0.160 |
Why?
|
| Liver Cirrhosis, Alcoholic | 2 | 2019 | 19 | 0.160 |
Why?
|
| Indenes | 1 | 2020 | 12 | 0.160 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2020 | 20 | 0.160 |
Why?
|
| Furans | 1 | 2020 | 28 | 0.160 |
Why?
|
| Sulfones | 1 | 2020 | 43 | 0.160 |
Why?
|
| Cough | 1 | 2021 | 183 | 0.150 |
Why?
|
| Dipeptides | 1 | 2020 | 68 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 178 | 0.150 |
Why?
|
| Acute-Phase Proteins | 1 | 2019 | 35 | 0.150 |
Why?
|
| Sulfonamides | 1 | 2020 | 136 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 37 | 0.140 |
Why?
|
| Exosomes | 1 | 2019 | 53 | 0.140 |
Why?
|
| Lysosomes | 1 | 2019 | 167 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 716 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2019 | 342 | 0.140 |
Why?
|
| Extracellular Traps | 1 | 2018 | 45 | 0.140 |
Why?
|
| Binge Drinking | 1 | 2018 | 38 | 0.130 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 92 | 0.130 |
Why?
|
| Intestines | 1 | 2018 | 178 | 0.130 |
Why?
|
| Kupffer Cells | 1 | 2017 | 43 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2018 | 257 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 66 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2012 | 514 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 105 | 0.120 |
Why?
|
| Syk Kinase | 1 | 2016 | 5 | 0.120 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 53 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 2274 | 0.120 |
Why?
|
| Oxazines | 1 | 2016 | 14 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 51 | 0.120 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2016 | 98 | 0.120 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2016 | 53 | 0.120 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2016 | 28 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 661 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 541 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1136 | 0.120 |
Why?
|
| Pyridines | 1 | 2016 | 115 | 0.110 |
Why?
|
| Cell Death | 1 | 2016 | 289 | 0.110 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 182 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2019 | 718 | 0.110 |
Why?
|
| Disease Progression | 1 | 2019 | 1213 | 0.110 |
Why?
|
| Sepsis | 1 | 2018 | 293 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 176 | 0.100 |
Why?
|
| Time Factors | 2 | 2018 | 3748 | 0.100 |
Why?
|
| Bacteria | 1 | 2017 | 336 | 0.100 |
Why?
|
| Gene Expression | 1 | 2017 | 849 | 0.100 |
Why?
|
| Middle Aged | 5 | 2024 | 18156 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2018 | 1574 | 0.090 |
Why?
|
| Lipopolysaccharides | 3 | 2022 | 623 | 0.090 |
Why?
|
| Liver | 1 | 2017 | 868 | 0.090 |
Why?
|
| Profilins | 1 | 2012 | 44 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2012 | 105 | 0.090 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2011 | 11 | 0.090 |
Why?
|
| Male | 8 | 2024 | 30840 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2019 | 1123 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1224 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2016 | 917 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1628 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2011 | 135 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2017 | 1550 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2011 | 389 | 0.080 |
Why?
|
| Humans | 10 | 2024 | 64768 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 449 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2022 | 1035 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 350 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 2024 | 66 | 0.050 |
Why?
|
| Mutation | 1 | 2012 | 2656 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2024 | 106 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2024 | 162 | 0.050 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2023 | 66 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2023 | 112 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 37 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2022 | 41 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 271 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 299 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2187 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 14882 | 0.040 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2019 | 7 | 0.040 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 14 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2019 | 38 | 0.040 |
Why?
|
| Adult | 3 | 2024 | 17251 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2019 | 14 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 114 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 132 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2018 | 26 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 292 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 221 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 413 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 576 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 303 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2017 | 50 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 735 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2016 | 11 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 927 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2019 | 433 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 203 | 0.030 |
Why?
|
| Monocytes | 1 | 2019 | 360 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 210 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2016 | 2 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2016 | 15 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2016 | 14 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 46 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1102 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 610 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 446 | 0.030 |
Why?
|
| Endotoxins | 1 | 2016 | 81 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1772 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1553 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 895 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1469 | 0.020 |
Why?
|
| Neutrophils | 1 | 2016 | 387 | 0.020 |
Why?
|
| Jews | 1 | 2012 | 10 | 0.020 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.020 |
Why?
|
| United States | 2 | 2019 | 8052 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 521 | 0.020 |
Why?
|
| Exome | 1 | 2012 | 69 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 1227 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 193 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2090 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 117 | 0.020 |
Why?
|
| Axons | 1 | 2012 | 123 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2144 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 197 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 156 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2012 | 218 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 263 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 309 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 790 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1589 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1979 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1160 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 880 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 2231 | 0.020 |
Why?
|